Hi, we're Reuters reporters investigating the worsening outcomes for Americans with diabetes despite billions spent on new treatments. Ask us anything!
In the current series “Out of Control,” we have reported on how the COVID-19 pandemic exposed another U.S. public health crisis as a disproportionate number of people with diabetes died. Years of inadequate treatment had left them particularly vulnerable to the virus and the isolation of lockdown. Deaths from diabetes last year surged 17% to more than 100,000, we found. This grim toll is the result of failures that long predate the pandemic. Despite billions of dollars spent on new treatments, the prognosis for people with diabetes has been getting worse as the number of people with the disease has increased, especially among working-age and even younger people.
In part two of the series, we reported on how pharmaceutical giants launched years-long marketing campaigns for a diabetes treatment target they helped create. As their sales of diabetes drugs soared, so did incidents of low blood sugar, a potentially deadly medication risk. While many diabetes patients struggle to obtain sufficient care, many others are chasing a treatment goal – known as A1c less than 7% – that could kill them. This risk is higher among older adults with diabetes.
I’m a heath care, financial and data journalist for Reuters based in the San Francisco bureau - Robin Respaut
I’m a health reporter in Los Angeles for Reuters who has previously investigated deceptive practices in health insurance, superbug outbreaks and a $3 billion accounting fraud - Chad Terhune